Program Future Medicine 2017

08:00 Admission and beginning of exhibition and networking

09:00 Opening: 
Sebastian Turner, Publisher, Der Tagesspiegel 
Prof. Martin Lohse, Spokesperson of the Executive Board, Berlin Institute of Health (BIH)

09:10 Welcome Address: Dr. Georg Schütte, State Secretary at the Federal Ministry of Education and Research

09:25 Moderation: Susan E. Knoll, Verlag Der Tagesspiegel

 

09:30 Session 1: Precision Medicine and Predictive Models

09:30 Keynote: Joel Dudley PhD, Icahn School of Medicine at Mount Sinai, New York City
Moving from Precision Medicine to Next Generation Healthcare

09:45 Short Presentations 

Prof. Frederick Klauschen, Charité – Universitätsmedizin Berlin
Integrated Analysis of Morphological and Molecular Tumor Properties Through Machine Learning

Till Hülnhagen, Max Delbrück Center for Molecular Medicine (MDC), Berlin
Toward Precision Diagnostics Using Ultrahigh Field Magnetic Resonance Imaging

Li Li, PhD, Harvard Medical School, Boston
The Aberrant Behaviors in ASD and Corresponding Mutations

Jin Hyung Lee, PhD, Stanford University
Optogenetic fMRI and the Investigation of Global Brain Circuit Mechanisms

Dr. Helena Radbruch, Charité – Universitätsmedizin Berlin
Oxidative Stress Fingerprint in Chronic Inflammation

Tõnu Esko, PhD, University of Tartu / Broad Institute, Cambridge
Mining Genealogies to Empower Genomics-Guided Personalized Medicine

Diana HeinrichsLindera GmbH, Berlin
Mobility in the Age of Personalized Care for the Elderly

Mahsa Moein, PhD, University of Luxembourg
Metabolic Decoding of Calcium Signals in Electrically Non-Excitable Cells

Dr. Anton G. Henssen, Charité – Universitätsmedizin Berlin
Shuffle up and Deal – How Recombinases Rearrange Pediatric Tumor Genomes

Prof. Frank Tüttelmann, University Hospital of Muenster
Older Fathers and Ageing Sperm: Risks for Offspring?

Dr. Ulrike Sack, Bayer AG, Berlin
Tackling Survival Signaling – Cancer’s Achilles Heel

Dr. Michal Or-Guil, Humboldt University of Berlin
Systems Immunology for Precision Medicine – Optimizing Immunosuppressive Treatment After Kidney Transplantation

Dr. Elizabeth Ford, Brighton and Sussex Medical School
ASTRODEM: Using Astrophysics to Close the Diagnosis Gap for Dementia

Prof. David Capper, Charité – Universitätsmedizin Berlin 
Classifying Brain Cancer by DNA Methylation Profiling

Dr. Daniel Freitag, Bayer AG, Berlin
Leveraging Nature’s Randomized Trials for Drug Discovery

Dr. Nicolle KränkelCharité – Universitätsmedizin Berlin
Neutrophils in acute myocardial infarction – Dr. Jekyll and Mr. Hyde

Dr. Daniel Ziemek, Pfizer Inc., Cambridge
Predictive Omics Modelling in our Clinical Trials: Using Prior Knowledge to Overcome the Curse of Dimensionality

Dr. Florian HerseMax Delbrück Center for Molecular Medicine (MDC), Berlin
Early Prediction of Preeclampsia

Dr. Mustafa Diken, TRON – Translational Oncology at the University Medical Center of Johannes Gutenberg University Mainz gGmbH
Personalized Cancer Vaccines

Dr. Felix B. Schwarz, Charité – Universitätsmedizin Berlin 
High Resolution Patient Equivalent 3D-Printed Phantoms for Computed Tomography and Radiation Therapy

Prof. Birgit Burkhardt, University Hospital of Muenster
The Challenge of Translational Science for Children with Lymphoma

Linda SundermannBielefeld University
Tumor Heterogeneity and Subclonal Composition Reconstruction

Dr. Frederik DammCharité – Universitätsmedizin Berlin  
Clonal Hematopoiesis: Where are we in 2017?

Atanas Kamburov, PhDBayer AG, Berlin
Mutational Clustering in Proteins Elucidates Cancer Mechanisms and Identifies Candidate Targets

Dr. Dietmar Frey, Charité – Universitätsmedizin Berlin
Predicting Stroke: Non-invasive Software for Precision Medicine in Stroke

Piotr Bucichowski, Charité – Universitätsmedizin Berlin
New Treatment Options for Hereditary Macular Degenerations: Lessons from Best´s Disease

Prof. Philip Rosenstiel, University Medical Center Schleswig-Holstein, Kiel
Therapy Response Prediction in Chronic Inflammatory Disease

Dr. Ahmed Hegazy, Charité – Universitätsmedizin Berlin
Patient Stratification and Targeting Novel Cytokine Pathways in Inflammatory Bowel Disease

Prof. Andreas ThielCharité – Universitätsmedizin Berlin
Immunological Help versus Kill - A New Division of Labour Concept for Immunity

 

11:10 Matching Break

 

11:50 Session 2: Digital Health and Big Data

11:50 Keynote: Prof. Erwin Böttinger, Hasso Plattner Institute for Digital Engineering gGmbH / University of Potsdam
'The Patient Will See You Now‘ - The Digital Transformation of Healthcare

 

12:05 Short Presentations 

Introduction:
Stefanie Stammler, AOK Nordost – Die Gesundheitskasse
Digital Health and How to Add Value to Insurants

Santosh Hariharan, PhD, HealthNextGen, Toronto
Monitoring Disease Progression with Predictive Clinical Biomarkers for Myaesthenia Gravis

Tom KaszemacherIcahn School of Medicine at Mount Sinai, New York City
Providing Real-Time Genomic-Driven Decision Support for Personalized Care

Dr. Felix Balzer, Charité – Universitätsmedizin Berlin
Making Better Decisions on the Intensive Care Unit: How Digitalization Helps Us

Dr. Nicolas Renier, ICM Brain & Spine Institute, Paris
Histology in the Third Dimension: Techniques for High-Throughput 3D Tissue Imaging and Data Analysis

Simon MoosburnerCharité – Universitätsmedizin Berlin
Virtual & Mixed Reality: The Next Milestone in Surgery?

Ásmundur Oddsson, PhDdeCODE genetics, Reykjavik
Genome-Wide Association Studies in the Icelandic Population

Ann-Kristin Kock-SchoppenhauerUniversity of Lübeck
Enabling Secondary Use of Clinical Care and Medical Research Data

Prof. Thomas NeumuthInnovation Center Computer Assisted Surgery, Universität Leipzig
Model-Based Computer-Assisted Therapy

Dr. Jörg LippertBayer AG, Berlin
Beyond Randomized Controlled Trials - New Source of Clinical Insight

Dr. Matthieu-P. Schapranow, Hasso Plattner Institute for Digital Engineering gGmbH, Potsdam
Smart Data for Smart Doctors: How Algorithms Support Fighting Complex Diseases

Dr. Samuel Knauss, Charité – Universitätsmedizin Berlin
Empowering The People - Saving Lives With Mobile Money

Dr. Gandolf Finke, Fosanis GmbH, Berlin
Transforming Cancer Care With Digital Patient Engagement

Dr. Alexander Meyer, German Heart Center Berlin
Real-Time Data-Driven Decision Support for Postoperative Intensive Care

Dr. Sarah Feger, Charité – Universitätsmedizin Berlin
Deep Learning for Cardiac CT

Dr. Baher Al HakimMedicus AI GmbH, Vienna
The Robot Will See You Now - A Short Exploration Into the Exciting Future of AI in Health

Keno Kyrill Bressem, Charité – Universitätsmedizin Berlin
Using Big Data to Identify Missed Care Opportunities

Dr. Stephan von Schorlemer, Hasso Plattner Institute for Digital Engineering gGmbH, Potsdam
Gesundheitscloud - A Patient-Centric Platform for Integrated Health Data

Dr. Florian Michallek,  Charité – Universitätsmedizin Berlin
Fractal Analysis of Myocardial Perfusion Imaging

 

13:00 Lunch Break

 

14:30 Political Keynote: Michael Müller, Governing Mayor of Berlin 

14:45 Session 3: Stem Cells and Human Disease Modeling

14:45 Keynote: Prof. Margaret Buckingham, Institut Pasteur, Paris
Skeletal Muscle Stem Cells and Their Regulation During Muscle Repair

15:00 Short Presentations 

Dr. Christopher EskInstitute of Molecular Biotechnology Austria (IMBA), Vienna
Parallel in Vivo Screening for Rapid Gene Function Discovery

Stefanie Seelk, Max Delbrück Center for Molecular Medicine (MDC), Berlin
The Histone-Chaperone LIN-53 has a Dual Function in Regulating Aging and Muscle Development

Dr. Christopher Patzke, Stanford University
The Conditional KO Approach: Cre/Lox Technology in Human Neurons

Dr. David SebingerCharité – Universitätsmedizin Berlin / BIH
Neuronal in Vitro Models for Epigenetically Related Obesity

Darío Garcia Lupiañez, Berlin Institute for Medical Systems Biology (BIMSB) / Max Delbrück Center for Molecular Medicine (MDC)
Structural Variation of the Human Genome: Order and Disorder

Dr. Emilie Plantié, Charité – Universitätsmedizin Berlin / Max Delbrück Center for Molecular Medicine (MDC), Berlin
Drosophila Melanogaster - A Screening Model for Identifying Candidate Genes Responsible for Congenital Heart Disease

Miguel Oliveira, PhD, University of Luxembourg
From Development Lineages to Mature Identity of Selective Vulnerable Neurons in Parkinson's Disease

Dr. Suphansa Sawamiphak, Max Delbrück Center for Molecular Medicine (MDC), Berlin
Heart Regeneration: Fishing for a Recipe

Dr. Markus Quante, University Hospital Tübingen
Natural Metabolites Reverse Obesity and Related Inflammation

Katrina Meyer, Max Delbrück Center for Molecular Medicine (MDC), Berlin
Mutations in Disordered Regions Cause Disease by Creating Endocytosis Motifs

Dr. Sylvie Picker-MinhCharité – Universitätsmedizin Berlin 
'Small Brains' – Novel Genetic Causes of Microcephaly 

Dr. Olaf PenackCharité – Universitätsmedizin Berlin
The Vasculature as Therapeutic Target During Inflammation

Dr. Daniela Panáková, Max Delbrück Center for Molecular Medicine (MDC), Berlin
Getting to the Heart of Things

Dr. Nadja Ehmke, Charité – Universitätsmedizin Berlin
De Novo Mutation Leading to Mitochondrial Dysfunction and Facial Bone Malformation

 

15:45 Matching Break

 

16:30 Session 4: Cell and Gene Therapies

16:30 Keynote: Dr. Michaela FryeUniversity of Cambridge
Discovery of the Epitranscriptome: From RNA Chemistry to Translational Research


16:45 Short  Presentations 

Raffaella Di Micco, PhDSan Raffaele Telethon Institute for Gene Therapy, Milan
Artifical Nucleases in the Hematopoietic Compartment: Understanding the Biology for a Better Cellular Product

Nisarg Shah, PhD, Harvard University, Boston
Biomaterials For Rebuilding Adaptive Immunity

Dr. Antonia Busse, Charité – Universitätsmedizin Berlin
Isolation of Tumor Specific T-Cells from Patients' Tumor or Peripheral Blood

Dr. Nico LachmannHannover Medical School
Next Generation of „Antibiotics“: Bioreactor Derived Immune Cells to Fight Infectious Diseases

Dr. Kathleen BörnerHeidelberg University Hospital
A CRISPR Way to Eradicate HIV From Human Cells

Josefine Gottschalk, Technical University of Applied Sciences Wildau / University of Rome 
Long-term Monitoring of Chemotherapeutic Induced Cell Reactions by ESPI

Dr. Lena Oevermann, Charité – Universitätsmedizin Berlin
Fecal Microbiota Transplantation as a Potential Therapy for Gastrointestinal Graft- Versus-Host Disease

Dr. Lars Böckmann, University of Lübeck and University Hospital Schleswig-Holstein, Campus Lübeck
Specifically Targeting Cancer Cells through Synthetic Lethality

Prof. Axel Schambach, Hannover Medical School
From a Cancer Causing Retrovirus to a Safer Tool for Gene Therapy

Dr. Maria Luisa Barcena de Arellano, Charité – Universitätsmedizin Berlin
Role of Sirt3 in the Anti-Inflammatory Effects of Estrogen Receptors Signaling

Dr. Vida Farsam, Max Delbrück Center for Molecular Medicine (MDC), Berlin
MDCell – The Cell Engineering Lab

Thilo Liebscher, Technical University of Applied Sciences Wildau / University of Rome 
Online Cell Vitality Monitoring in Miniaturised Cell Culture

 

17:30 Farewell

17:30 Get Together